About
Neuronano AB is a Swedish medtech company developing ultrathin, flexible electrode cluster technology and biodegradable carrier implants for deep brain stimulation (DBS) to treat conditions such as Parkinson’s disease, pain and epilepsy; their probes are reported to be in preclinical testing in collaboration with Lund University and Aarhus University.
Explore Neuronano AB's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.